Curaleaf Holdings, Inc.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

NEW YORK , April 4, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the first quarter ended March 31, 2024 after market close on May 9, 2024. Management will host a conference call and audio webcast that afternoon at 5:00 p.m.

Curaleaf to Report First Quarter 2024 Financial and Operational Results

Cronos Group

Tilray Brands

Over the last few years, cannabis stocks have struggled and trended lower. The two negatives being regulatory headwinds and cash burn.

The 3 Most Undervalued Cannabis Stocks to Buy in April 2024

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

The Florida Supreme Court on Monday ruled in favor of allowing Florida voters to decide whether cannabis can be sold to adults 21 and over through a referendum on the November ballot.

Florida Supreme Court OKs adult-use cannabis referendum for November ballot in victory for pot companies

Aurora Cannabis

Canopy Growth

What Cannabis Reform In Germany Means For North American Marijuana Companies

Cannabis stocks for your late March 2024 watchlist.

2 Cannabis Stocks To Watch In Late-March 2024

Appian

Cognex

Gildan Activewear

MasTec

Teradyne

Welltower

With the equities market continuing to march higher, now may be an ideal time to consider sleeper stocks. Essentially, these are companies that attract little interest among investors.

Wake Up to Wealth: 7 Sleeper Stocks Ready to Roar

In the last few years, cannabis stocks have been impacted by two factors. First, regulatory headwinds have played a spoilsport for an industry with huge potential.

3 Cannabis Stocks That Could Be Multibaggers in the Making: March Edition

Marijuana stock investors are looking to take profits any way they can. For some time much of the sector has lacked consistent momentum. Unless there is news or a catalyst big enough to move the sector. 2024 has a lot to offer the cannabis industry that could play out well for investors. More companies are working on many new projects and ventures. Some have partnered up with other companies and some have ramped up its current production with new products.

These Marijuana Stocks Could See Big Gains In 2024

LONDON--(BUSINESS WIRE)--German Federal Government's cannabis law has successfully progressed without delay. Juan Martinez, Head of Curaleaf International, comments.

Curaleaf International Comments As German Federal Cannabis Law Passes Without Delay

DraftKings

EHang Holdings Ltd - ADR

Lithium Americas Corp

Li Auto Inc.

MINISO Group Holding

Riot Blockchain

If the investment objective is to make millions from the market, it's essential to remain equal weight or overweight on growth stocks. A good selection of blue-chip stocks can offer returns that consistently beats the index.

7 Growth Stocks That Could Turn $10,000 into $70,000 by 2028

If you're looking for Wall Street's favorite cannabis stocks, you're most likely to find them amongst the holdings of the AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS ), the largest U.S.-listed cannabis exchange traded fund (ETF). MSOS is an actively managed ETF with just under $1 billion in net assets.

Wall Street's Favorite Cannabis Stocks? 3 Names That Could Make You Filthy Rich

Marijuana stocks have seen a slight increase in momentum throughout March. Much of which has to do with the politics surrounding cannabis laws. Currently, cannabis is still federally illegal even though more than half of the USA has legalized it in some form. As well as several other regions around the world. This has been an ongoing issue for many years. Yet the cannabis industry has found a way to grow and thrive which has brought more attention to it.

The Best Marijuana Stocks For New Investors

AdvisorShares Pure US Cannabis ETF

President Joe Biden recently mentioned marijuana in his State of the Union address. Cannabis may come back into the spotlight this year, and it could potentially sway some voters.

Cannabis Stocks Could Get a Lift From an Unexpected Catalyst Later This Year

Lundin Mining Corporation

OTC stocks often go unnoticed as there is an ocean of ideas to research and buy from the main exchanges. That's understandable also because liquidity is higher in the main exchanges as compared to the OTC exchange.

3 OTC Stocks With the Potential to Deliver Multibagger Paydays by 2026

While New York and New Jersey share a border along the Hudson River, they've been far apart in their rollouts of licensed recreational-pot sales over the past three years.

What New Jersey did right — and New York did wrong — with recreational-cannabis launches

Deal Provides Curaleaf Strategic Supply Chain Advantage in Key Growth Markets of Germany, Poland, U.K. and Establishes Presence in Australia and New Zealand    NEW YORK , March 19, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced it has signed a deal to acquire Northern Green Canada ("NGC"), a vertically integrated Canadian licensed cannabis producer focused primarily on expanding in the international market through its EU-GMP certification. NGC also partners with Canadian GACP cultivators to produce and distribute finished cannabis products to both the domestic and global markets.

Curaleaf to Acquire Northern Green Canada to Bolster European Flower Supply

It is a good Monday for Cannabis stocks. Canopy Growth (CGC), Curaleaf (CURLF),  and Aurora Cannabis (ACB) stock prices surged by more than 10% in the pre-market session.

Aurora Cannabis, Canopy Growth, Curaleaf stocks spiked: here's why

LONDON--(BUSINESS WIRE)--Curaleaf International, one of Europe's largest vertically integrated cannabis companies, is expanding into the Czech Republic.

Curaleaf International Expands into Czech Republic with Astrasana Pharma Partnership

Curaleaf Holdings, Inc. remains bullish on the cannabis market due to adult-use state programs and European approvals, rather than changes in U.S. federal regulations. The opening of the New York legal cannabis market presents a significant opportunity for Curaleaf, with the company already establishing a strong brand position in the medical cannabis market. Curaleaf sees potential for significant revenue growth in states like Florida, Ohio, Pennsylvania, as well as in European countries like Germany, the UK, and Poland.

Curaleaf: New York To The Rescue

Innovative Industrial Properties

Amidst a shifting landscape, undervalued cannabis stocks are catching the eye of savvy investors. The U.S. government's potential de-scheduling of marijuana and a Gallup survey revealing a 70% approval rate for federal-level legalization signal a notable shift in public sentiment and policy.

The 3 Most Undervalued Cannabis Stocks to Buy in March 2024

Cannabis stocks have gone through multiple phases of high volatility in the last five years. Traders might have benefited from this volatility, but the sector has disappointed long-term investors.

Budding Millionaires: 3 Cannabis Stocks With 5-Bagger Potential by 2025

Divergent views on Curaleaf between SA Analysts (sell) and Wall Street (strong buy) amid recent stock correction. Curaleaf shows strong financial results in 2023, leading in revenue among MSOs. The over-excitement on Curaleaf's TSX debut as well as its international exposure may have been overshadowed by recent increased likelihood of rescheduling cannabis in the U.S.

Curaleaf: Wild Divide Between Wall Street And SA Analysts Sentiments

As we head for the second quarter of 2024, the US cannabis industry and top marijuana stocks offer intriguing investment opportunities amid evolving legal landscapes and consumer trends. Top cannabis companies diversify their offerings, expand into new markets, and solidify their financial standings, signaling robust growth prospects. This sector's dynamism, driven by legislative advancements and changing societal attitudes toward cannabis use, underscores its potential for investors.

March 2024 Watchlist: Leading Marijuana Stocks in the US Market

Curaleaf's share price has doubled since early February 2024, defying a bearish outlook. The lack of federal legalization is hindering the U.S. cannabis industry's growth potential. CURLF's market cap has increased by 74.4% since May 2023, making it the top marijuana company by market cap.

Curaleaf Stock: The Rally Stalls After Q4 Earnings

Curaleaf Holdings, Inc. (OTCPK:CURLF) Q4 2023 Earnings Conference Call March 6, 2024 5:00 PM ET Corporate Participants Camilo Lyon - Chief Investment Officer Boris Jordan - Executive Chairman Matt Darin - Chief Executive Officer Ed Kremer - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Russell Stanley - Beacon Securities Matt Bottomley - Canaccord Genuity Scott Fortune - ROTH MKM Sonny Randhawa - Seaport Research Partners Eric Des Lauriers - Craig Hallum Capital Group Pablo Zuanic - Zuanic & Associates Operator Hello and welcome to the Curaleaf Holdings Inc. Fourth Quarter and Fiscal Year End 2023 Earnings Conference Call. All participants will be in listen-only mode.

Curaleaf Holdings, Inc. (CURLF) Q4 2023 Earnings Call Transcript

News for Curaleaf Holdings, Inc. Stock (CURLF)